Polen Capital's position in Thermo Fisher Scientific is currently worth $1.1 Billion. That's 2.55% of their equity portfolio (15th largest holding). Polen Capital started to build up the position in Thermo Fisher Scientific in Q4 2022 and continued to invest until Q1 2023. Since then they sold 238 Thousand shares. The stake costed the investor $1.08 Billion, netting the investor a gain of 2.0% so far.
On CNBC’s " Halftime Report Final Trades ," Stephen Weiss of Short Hills Capital Partners picked GXO Logistics, Inc. (NYSE: GXO ), saying they do well each q...
Benzinga, 16 days ago… funds and other institutional investors have also recently added … last quarter. Summit Global Investments raised its stake in shares … third quarter. Summ...
EIN News Investing, 4 months ago… Commission (SEC). The institutional investor purchased 15,900 shares … 164,000. Other institutional investors and hedge funds have also … .71. Want More Gr...
EIN News Investing, 7 months agoCatalyst Capital Advisors LLC raised its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Rating) by 27.6% in the fourth quarter, accordin...
The AM Reporter, 11 months ago